Clinical presentation of intoxication due to synthetic cannabinoids

Pediatrics

Volumn 129, Issue 4, 2012, Pages

  Cohen, Joanna ^a   Morrison, Sephora ^a   Greenberg, Jeffrey ^a   Saidinejad, Mohsen ^a  

^a CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

Author keywords

Cannabinoids; Intoxication; K2; Spice; Substance abuse

Indexed keywords

CANNABINOID; DIPHENHYDRAMINE; LORAZEPAM;

ADOLESCENT; ADULT; AGGRESSION; AGITATION; ARTICLE; BLOOD PRESSURE MEASUREMENT; BREATHING RATE; CASE REPORT; CATATONIA; CLINICAL EXAMINATION; CLINICAL FEATURE; DIAPHORESIS; DIZZINESS; DRUG INTOXICATION; FEMALE; HEADACHE; HEART RATE; HUMAN; LUNG EXAMINATION; MALE; MENTAL DISEASE; NYSTAGMUS; OXYGEN SATURATION; PAIN; PRIORITY JOURNAL; RESTLESSNESS; SINUS TACHYCARDIA; TREATMENT RESPONSE; VERBALIZATION; WAKEFULNESS;

EID: 84859401249     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2011-1797     Document Type: Article

References (16)

1. Chemicals used in "Spice" and "K2" type products now under federal control and regulation. Springfield, VA: US Drug Enforcement Administration; March 1, 2011. Available at: www.justice.gov/dea/pubs/pressrel/ pr030111.html
2. Wells DL, Ott CA. The "new" marijuana. Ann Pharmacother. 2011;45(3):414-417
3. Piggee C. Investigating a not-so-natural high. Anal Chem. 2009;81(9):3205-3207
4. Lindigkeit R, Boehme A, Eiserloh I, et al. Spice: a never ending story? Forensic Sci Int. 2009;191(1-3):58-63
5. Wehrman J. Fake marijuana spurs more than 4,500 calls to US poison centers. Alexandria, VA: American Association of Poison Control Centers; 2011 Available at: www.aapcc.org/ dnn/Portals/0/prrel/revisedk2releaseapril20. pdf. Accessed May 7, 2011
6. Hudson S, Ramsey J, King L, et al. Use of high-resolution accurate mass spectrometry to detect reported and previously unreported cannabinomimetics in "herbal high" products. J Anal Toxicol. 2010;34(5): 252-260
7. Atwood BK, Huffman J, Straiker A, Mackie K. JWH018, a common constituent of 'Spice'herbal blends, is a potent and efficacious cannabinoid CB receptor agonist. Br J Pharmacol. 2010;160(3):585-593
8. Ashton JC, Wright JL, McPartland JM, Tyndall JD. Cannabinoid CB1 and CB2 receptor ligand specificity and the development of CB2-selective agonists. Curr Med Chem. 2008;15(14):1428-1443 (Pubitemid 351997793)
9. Vearrier D, Osterhoudt KC. A teenager with agitation: higher than she should have climbed. Pediatr Emerg Care. 2010;26(6):462-465
10. Hoffman AF, Lupica CR. Mechanisms of cannabinoid inhibition of GABA(A) synaptic transmission in the hippocampus. J Neurosci. 2000;20(7):2470-2479 (Pubitemid 30220334)
11. Rodgman C, Kinzie E, Leimbach E. Bad Mojo: use of the new marijuana substitute leads to more and more ED visits for acute psychosis. Am J Emerg Med. 2011;29(2):232
12. Fox SH, Kellett M, Moore AP, Crossman AR, Brotchie JM. Randomised, double-blind, placebo-controlled trial to assess the potential of cannabinoid receptor stimulation in the treatment of dystonia. Mov Disord. 2002;17(1):145-149 (Pubitemid 36041271)
13. Mustata C, Torrens M, Pardo R, Pérez C, FarréM; Psychonaut Web Mapping Group. Spice drugs: cannabinoids as a new designer drugs [in Spanish]. Adicciones. 2009;21(3):181-186
14. Schneir AB, Cullen J, Ly BT. "Spice" girls: synthetic cannabinoid intoxication. J Emerg Med. 2011;40(3):296-299
15. Moran CL, Le VH, Chimalakonda KC, et al. Quantitative measurement of JWH-018 and JWH-073 metabolites excreted in human urine. Anal Chem. 2011;83(11):4228-4236
16. Montecucco F, Burger F, Mach F, Steffens S. CB2 cannabinoid receptor agonist JWH-015 modulates human monocyte migration through defined intracellular signaling pathways. Am J Physiol Heart Circ Physiol. 2008; 294(3):H1145-H1155 (Pubitemid 351468709)